Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

bioAffinity Technologies (BIAF) Receivables - Other (2022 - 2026)

bioAffinity Technologies has reported Receivables - Other over the past 5 years, most recently at $32497.0 for Q1 2026.

  • Quarterly Receivables - Other rose 86.97% to $32497.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $32497.0 through Mar 2026, up 86.97% year-over-year, with the annual reading at $26295.0 for FY2025, 5.66% down from the prior year.
  • Receivables - Other was $32497.0 for Q1 2026 at bioAffinity Technologies, up from $26295.0 in the prior quarter.
  • Over five years, Receivables - Other peaked at $119363.0 in Q2 2024 and troughed at $4730.0 in Q3 2023.
  • The 5-year median for Receivables - Other is $27508.5 (2024), against an average of $35014.8.
  • Year-over-year, Receivables - Other surged 940.02% in 2024 and then tumbled 83.65% in 2025.
  • A 5-year view of Receivables - Other shows it stood at $10489.0 in 2022, then surged by 181.75% to $29553.0 in 2023, then decreased by 5.68% to $27874.0 in 2024, then fell by 5.66% to $26295.0 in 2025, then rose by 23.59% to $32497.0 in 2026.
  • Per Business Quant, the three most recent readings for BIAF's Receivables - Other are $32497.0 (Q1 2026), $26295.0 (Q4 2025), and $27143.0 (Q3 2025).